Keeping up with corporate filings shouldn't be a full-time job.

Lack of time and motivation to wade through dense documents means missing out on portfolio-boosting opportunities.

Stay informed, invest smarter: AI-powered corporate filing summaries.

Setup Free Alerts → Browse Latest Filings
Sign up to stay up to date with the stocks you care about

Most recent public disclosures: AI-powered summaries of the latest corporate filings

2851
1
Nextdoor Holdings, Inc. Nextdoor Reports 17% Revenue Growth, Net Loss Improvement in Q3 2024

Via official filing (AI summary) | 18 days ago | 0 comments

2852
1
Personalis, Inc. Personalis Reports 41% Revenue Growth, Net Loss in Q3 2024

Via official filing (AI summary) | 18 days ago | 0 comments

2853
1
Allakos Inc. Allakos Inc. Reports Significant Financial Decline, Net Loss in Latest Quarter

Via official filing (AI summary) | 18 days ago | 0 comments

2854
1
INNOVATE Corp. INNOVATE Corp. Reports Revenue Decline, Net Losses, and Strategic Initiatives in Q3 2024

Via official filing (AI summary) | 18 days ago | 0 comments

2855
1
Grocery Outlet Holding Corp. Grocery Outlet Reports 9.9% Revenue Growth, Net Income Decline in 39-Week Period Ended September 28, 2024

Via official filing (AI summary) | 18 days ago | 0 comments

2856
1
Xencor Inc Xencor Reports Significant Revenue Decline and Increased Losses in Q3 2024

Via official filing (AI summary) | 18 days ago | 0 comments

2857
1
Aadi Bioscience, Inc. Aadi Bioscience Reports Q3 2024 Financial Results, Product Sales Growth, and Reduced Net Loss

Via official filing (AI summary) | 18 days ago | 0 comments

2858
1
Caribou Biosciences, Inc. Caribou Biosciences Reports Significant Financial Decline, Net Loss Widens in Latest Quarter

Via official filing (AI summary) | 18 days ago | 0 comments

2859
1
CATALYST PHARMACEUTICALS, INC. Catalyst Pharmaceuticals Reports Significant Revenue Growth and Improved Financials in Latest Quarter

Via official filing (AI summary) | 18 days ago | 0 comments

2860
1
PROFIRE ENERGY INC Profire Energy Reports Modest Revenue Growth, Decline in Profitability in Q3 2024

Via official filing (AI summary) | 18 days ago | 0 comments

2861
1
Grand Canyon Education, Inc. Grand Canyon Education Reports 7.4% Revenue Growth, 16.0% Net Income Increase in Q3 2024

Via official filing (AI summary) | 18 days ago | 0 comments

2862
1
Arcutis Biotherapeutics, Inc. Arcutis Biotherapeutics Reports 17% Revenue Growth, 452% Increase in Product Revenue in Q3 2024

Via official filing (AI summary) | 18 days ago | 0 comments

2863
1
IONIS PHARMACEUTICALS INC Ionis Pharmaceuticals Reports Mixed Q3 Results, Net Loss Improves

Via official filing (AI summary) | 18 days ago | 0 comments

2864
1
TEVA PHARMACEUTICAL INDUSTRIES LTD Teva Pharmaceutical Reports 13% Revenue Growth, Net Loss in Q3 2024 Due to Increased Legal Settlements and Goodwill Impairment

Via official filing (AI summary) | 18 days ago | 0 comments

2865
1
SOLENO THERAPEUTICS INC Soleno Therapeutics Reports Significant Financial Changes, Net Losses Increase 673% in Q3 2024

Via official filing (AI summary) | 18 days ago | 0 comments

2866
1
Blue Owl Capital Corp III Blue Owl Capital Corporation III Reports Mixed Financial Results in Latest 10-Q Filing

Via official filing (AI summary) | 18 days ago | 0 comments

2867
1
Celldex Therapeutics, Inc. Celldex Therapeutics Reports 110% Revenue Growth, Operating Losses Widen in Q3 2024

Via official filing (AI summary) | 18 days ago | 0 comments

2868
1
FIRST BANCORP /NC/ First Bancorp Reports Strong Cash and Deposit Growth, Net Income Decline in Q3 2024

Via official filing (AI summary) | 18 days ago | 0 comments

2869
1
Precipio, Inc. Precipio Reports 15% Revenue Growth, Net Loss Reduction in Q3 2024

Via official filing (AI summary) | 18 days ago | 0 comments

2870
1
TRANSCAT INC Transcat, Inc. Reports 8% Revenue Growth, Strong Net Income in Q2 and First Half of Fiscal Year 2025

Via official filing (AI summary) | 18 days ago | 0 comments

2871
1
8X8 INC /DE/ 8x8 Reports Decline in Revenue, Increase in Operating Expenses, and Net Loss in Q3 2024

Via official filing (AI summary) | 18 days ago | 0 comments

2872
1
Merck & Co., Inc. Merck Reports 4% Sales Growth, Mixed Profitability in Q3 2024

Via official filing (AI summary) | 18 days ago | 0 comments

2873
1
Longwen Group Corp. Wenyuan Group Reports Significant Revenue Growth and Improved Financial Performance in Q3 2024

Via official filing (AI summary) | 18 days ago | 0 comments

2874
1
Quantum Computing Inc. Quantum Computing Inc. Reports 102% Revenue Growth, Improved Losses, and Enhanced Working Capital in Q3 2024

Via official filing (AI summary) | 18 days ago | 0 comments

2875
1
ProFrac Holding Corp. ProFrac Holding Corp. Reports Mixed Q3 Results Amid Challenging Market Conditions

Via official filing (AI summary) | 18 days ago | 0 comments